investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Understanding the Function of TRIM 24 in Mammary Epithelial Cells
Aundrietta De Van Duncan
0 Collaborator(s)
Funding source
National Institutes of Health (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Aundrietta De Van Duncan
University of Texas MD Anderson Cancer Center
Houston, United States
Related projects
Kristina Cotter
Elucidating the Role of Plasma Membrane V-ATPases in Breast Cancer Metastasis
Breast
Pathology
Nathanael S Gray
Developing Selective EphA2 Inhibitors for the Treatment of Cancer
Breast
Sergey Korolev
Structural and Functional Studies of Tumor Suppressor Proteins PALB2 and BRCA2
Breast
Brian S Schaffhausen
Products of the Transforming Genes of Polyomavirus
Breast
Pathology
Shyam Sharan
Identification of Genetic Interactors of Brca2
Breast
Joseph Yesselman
Toward Atomic-Accuracy Design of Functional RNAs
Breast
Lewis A Chodosh
Minimal Residual Disease and Mechanisms of Breast Cancer Recurrence
Breast
Renato V Iozzo
Altered Proteoglycan Gene Expression and Cancer
Breast
Powel Brown
A MULTICENTER PHASE II STUDY OF DOCOSAHEXAENOIC ACID IN PATIENTS WITH A HISTORY OF BREAST CANCER, PREMALIGNANT LESIONS, OR BENIGN BREAST DISEASE
Breast